You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
In February 2005, Insulet Corporation of Bedford, Massachusetts, announced that its OmniPod Insulin Management System received FDA approval.
The OmniPod, according to Insulet, is a “two-part system combining the proven healthcare benefits of continuous subcutaneous insulin delivery and blood glucose monitoring technology.”
The system will be available by prescription later this year.
“The OmniPod Insulin Management System builds upon the safety and reliability of today’s conventional insulin pumps while incorporating new technology and features that offer unprecedented performance, convenience and ease of use,” says a spokesperson for Insulet. “Similar to currently available insulin pumps, the system features fully programmable continuous subcutaneous insulin delivery with multiple basal rates and bolus options, suggested bolus calculations, safety checks and alarm features. It also incorporates blood glucose monitoring technology.”
The OmniPod is small, lightweight and combines an integrated infusion set, automatic inserter and insulin reservoir.
Each OmniPod is worn for up to three days. It is then removed and replaced with a new pod.
* * *
Source: Insulet Corporation
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.